En serio hay que corregir todo lo que traes ?InkeyZero escribió: Jue Dic 30, 2021 12:25 pmOk. Lo que te haga feliz.Buzz escribió: Jue Dic 30, 2021 12:02 pmUd. miente descaradamente. La CDC cuenta todos los casos positivos, vacunados o no, con historia previa o no de infección.InkeyZero escribió: Jue Dic 30, 2021 11:49 am Los CDC dejaron de contar en mayo los casos breakthrough que no terminan en hospitalización. Habría que preguntarse si en la India hacen algo por el estilo.
https://www.npr.org/2021/08/12/10271985 ... ough-caseshttps://www.kiro7.com/news/local/cdc-no ... WMHXZVWMQ/By now, many Americans know someone who's been fully vaccinated but still got a breakthrough infection of COVID-19. To be clear, the Centers for Disease Control and Prevention still says that these cases are uncommon and only a tiny percentage of those uncommon breakthrough infections require hospitalization. But back in May, the CDC stopped tracking breakthrough infections unless they were severe. And that was before the highly contagious delta variant drove a new surge of COVID-19 throughout the country. So is this still the best practice? Well, vaccine expert Saad Omer joins us now. He's also the director of the Yale Institute for Global Health.https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e3.htmCDC no longer tracking all ‘breakthrough’ COVID-19 cases
August 10, 2021 at 7:35 pm PDT
By Gary Horcher, KIRO 7 News
After attending an outdoor wedding in Snohomish County, Chuck Wotipka was informed several people had tested positive for COVID-19 in the days that followed. Wotipka was vaccinated, so he figured his odds of becoming sick were low.
And then the symptoms hit him. “I was pretty much bedridden with extreme fever, stuffy nose, sore throat, just like a very bad case of the flu,” he said. Soon, he discovered he is among a growing number of people with “breakthrough” COVID-19 cases (those fully vaccinated and still got sick).
He was even more unpleasantly surprised that the Centers for Disease Control and Prevention does not track breakthrough cases like his unless there is a hospitalization. “For the general public to understand that more people are getting sick is really irrelevant information,” he said. “But if I’m a vaccinated person, and I understand there are a significant number of people like me getting sick, I might take more precautions because I think we all become a little more complacent after becoming vaccinated.”
The Snohomish County’s health district told KIRO 7 News it does track breakthrough COVID-19 cases and collects details it doesn’t publish on the website.
It tries to track which specific COVID-19 vaccines show up more often in breakthrough cases. The data shows over a three-week period between July 1 and July 20, there were 208 people infected with COVID-19 who were at least partially vaccinated —which equals 17% of all positive COVID-19 cases.
Its data for June shows if someone in Snohomish County is unvaccinated, they are 10 times more likely to become infected or die of COVID-19.
The CDC indicated on its website that it no longer has the staffing or resources to gather and process all data regarding breakthrough cases. Thus, it will concentrate on severe cases, hospitalizations and deaths. Wotipka believes more data regarding specific vaccines being involved in breakthrough cases will be more than “fun facts.”
“More data, more information saves lives,” Wotipka said. “The more information we have, the better off we’ll all be.”
©2021 Cox Media GroupBeginning May 1, 2021, CDC transitioned from monitoring all reported COVID-19 vaccine breakthrough infections to investigating only those among patients who are hospitalized or die, thereby focusing on the cases of highest clinical and public health significance. CDC will continue to lead studies in multiple U.S. sites to evaluate vaccine effectiveness and collect information on all COVID-19 vaccine breakthrough infections regardless of clinical status. Additional information and resources to help public health departments and laboratories investigate and report COVID-19 vaccine breakthrough cases are available at https://www.cdc.gov/vaccines/covid-19/h ... cases.html.
COVID-19 Vaccine Breakthrough Case Investigation and Reporting
Updated Oct. 28, 2021
For local health departments, healthcare providers, and clinical laboratories
CDC encourages local health departments, healthcare providers, and clinical laboratories that identify a COVID-19 vaccine breakthrough case to:
Request the respiratory specimen be held for further testing.
Report the case to the state health department where the individual resides for further investigation and reporting to the national system.
COVID-19 vaccine breakthrough cases that result in hospitalization or death should be reported to the Vaccine Adverse Event Reporting System (VAERS)external icon.
For state health departments
If a possible vaccine breakthrough case is identified:
Request that the clinical or public health laboratory hold any residual respiratory specimens from the positive SARS-CoV-2 test.
Report the available case data to NNDSS, per normal procedures.
Review CDC’s screening questions to assess whether the case meets the COVID-19 vaccine breakthrough investigation criteria.
If the reported case meets those criteria, CDC encourages state health departments to:
Follow the steps for initiating a COVID-19 vaccine breakthrough case investigation.
Record the case in the COVID-19 vaccine breakthrough REDCap database.
Because CDC would like to characterize the SARS-CoV-2 lineages responsible for COVID-19 vaccine breakthrough cases, including variants, CDC requests state health departments to:
Report sequence results from a state public health laboratory, commercial reference laboratory, or academic laboratory by entering the PANGO lineage and GenBank or GISAID accession number into the COVID-19 vaccine breakthrough REDCap database.
If SARS-CoV-2 sequencing will not be performed locally and an acceptable clinical respiratory specimen is available, provide instructions for the testing laboratory to send the residual respiratory specimen to CDC.
For cases with a known RT-PCR cycle threshold (Ct) value, submit only specimens with Ct value ≤28 to CDC for sequencing. (Sequencing is not feasible with higher Ct values.)
If the Ct value is not known (e.g., positive by antigen test only or by a molecular test that does not provide a Ct value), submit the positive specimen may still be submitted to CDC for RT-PCR and possible sequencing.
https://www.cdc.gov/coronavirus/2019-nc ... rough.html